Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial

PaperCitations, authors & open-access status

490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2025 year and closed oa status.

0
Citations
2025
Year
closed
OA Status

Related on ScholarIQ

Xiaoyu Jia
Author
Suneel Mundle
Author
Anildeep Singh
Author
H. Guo
Author
H. Luo
Author
Annals of Oncology
Journal
470M+ articles · free account